Shrink Nanotechnologies and Co-Founder Michelle Khine Listed in Fast Company Magazine's 100 Most Creative People in Business for 2011

IRVINE, Calif., May 24, 2011 /PRNewswire/ -- Shrink Nanotechnologies, Inc. ("Shrink") (OTC Markets: INKN), an innovative high technology innovation and development company, announced today that it was named along with its co-founder, Dr. Michelle Khine, in Fast Company's list of the Most Creative People in Business for 2011.  The Fast Company list, which includes individuals across a wide spectrum of industries, from media to high technology and all points in between, places Shrink Nanotechnologies and Dr. Michelle Khine as number 87 of 100.  The online version of the magazine includes a video highlight of Shrink's initial product offering, the StemDisc 450, which is being launched very shortly.  The latest edition of Fast Company magazine is available on newsstands and online at www.fastcompany.com.

About Shrink Nanotechnologies, Inc.

Shrink Nanotechnologies, Inc. is a FIGA™ organization, focusing on leveraging contributions from experts in Finance, Industry, Government and Academia. Operating as a high-technology development-stage company, Shrink licenses, owns and in all cases develops proprietary and patent-pending nano-sized technologies, components and product systems for a number of leading edge technology markets of varying sizes. For more information, please visit www.shrinknano.com.

Contact Shrink Nanotechnologies, Inc:
Mark L. Baum, CEO
(760) 804-8844
(760) 804-8845 Fax

Statements contained herein that are not historical facts may be forward-looking statements within the meaning of the Securities Act of 1933, as amended. Forward-looking statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements are estimates only. Actual results may differ materially from those anticipated in this press release due to a myriad of factors given the stage of development of Shrink. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Shrink is a development stage company and any investment in Shrink should only be made after (i) review of our public filings with the U.S. Securities and Exchange Commission (www.sec.gov), particularly the "Risk Factors" in our most recent Form 10-K, and (ii) after counsel from a registered investment professional.

(Logo:  http://photos.prnewswire.com/prnh/20101015/SHRINKLOGO)

SOURCE Shrink Nanotechnologies, Inc.